Evidence map›Paper›PMID 36988771›Full record

ArticleCellular and molecular neurobiology2023

CDK10, CDK11, FOXO1, and FOXO3 Gene Expression in Alzheimer's Disease Encephalic Samples.

Bruno Mari Fredi, Roger Willian De Labio, Lucas Trevizani Rasmussen, Eduardo Federighi Baisi Chagas, Elizabeth Suchi Chen, Gustavo Turecki, Marilia de Arruda Cardoso Smith, Spencer Luiz Marques Payão

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. CMGC Kinases in Viral Infection and Human Disease.Pathogens (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. BGMDB: A curated database linking gut microbiota dysbiosis to brain disorders.Computational and structural biotechnology journal · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Bruno Mari FrediMarilia Medical School (FAMEMA), Marilia, São Paulo, Brazil. bruno.fredi@famema.br.ORCID http://orcid.org/0000-0001-6316-6989
Roger Willian De LabioMarilia Medical School (FAMEMA), Marilia, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-6901-6663
Lucas Trevizani RasmussenMarilia Medical School (FAMEMA), Marilia, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-9033-2257
Eduardo Federighi Baisi ChagasMarilia Medical School (FAMEMA), Marilia, São Paulo, Brazil.ORCID http://orcid.org/0000-0001-6901-9082
Elizabeth Suchi ChenEscola Paulista de Medicina, Federal University of São Paulo, São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-3573-0164
Gustavo TureckiThe Douglas-Bell Canada Brain Bank, Douglas Mental Health University, Montreal, QC, Canada.ORCID http://orcid.org/0000-0003-4075-2736
Marilia de Arruda Cardoso SmithEscola Paulista de Medicina, Federal University of São Paulo, São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-1441-1033
Spencer Luiz Marques PayãoMarilia Medical School (FAMEMA), Marilia, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-4373-7742
Faculdade de Medicina de Marília · BRUniversidade Federal de São Paulo · BRDouglas Mental Health University Institute · CA

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.609695/2021-00
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a progressive neuroinflammatory and neurodegenerative disorder that affects different regions of the brain. Its pathophysiology includes the accumulation of β-amyloid protein, formation of neurofibrillary tangles, and inflammatory processes. Genetic factors are involved in the onset of AD, but they are not fully elucidated. Identification of gene expression in encephalic tissues of patients with AD may help elucidate its development. Our objectives were to characterize and compare the gene expression of CDK10, CDK11, FOXO1, and FOXO3 in encephalic tissue samples from AD patients and elderly controls, from the auditory cortex and cerebellum. RT-qPCR was used on samples from 82 individuals (45 with AD and 37 controls). We observed a statistically significant increase in CDK10 (p = 0.029*) and CDK11 (p = 0.048*) gene expression in the AD group compared to the control, which was most evident in the cerebellum. Furthermore, the Spearman test demonstrated the presence of a positive correlation of gene expression both in the auditory cortex in the AD group (r = 0.046/p = 0.004) and control group (r = 0.454/p = 0.005); and in the cerebellum in the AD group (r = 0.654 /p < 0.001). There was no statistically significant difference and correlation in the gene expression of FOXO1 and FOXO3 in the AD group and the control. In conclusion, CDK10 and CDK11 have high expression in AD patients compared to control, and they present a positive correlation of gene expression in the analyzed groups and tissues, which suggests that they play an important role in the pathogenesis of AD.

Indexed as

Alzheimer DiseaseAgedAmyloid beta-PeptidesBrainCyclin-Dependent KinasesForkhead Box Protein O1Forkhead Box Protein O3Gene ExpressionHumansNeurofibrillary TanglesAmyloid beta-PeptidesCDK10 protein, humanCyclin-Dependent KinasesForkhead Box Protein O1Forkhead Box Protein O3FOXO1 protein, humanFOXO3 protein, humanAlzheimer-diseaseCDKsDementiaFOXOsGene-expression

Identifiers

PMID36988771
PMCPMC11410123
OpenAlexW4361298816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.